Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Autoimmune Disorders

  Free Subscription

Articles published in Curr Opin Immunol

Retrieve available abstracts of 48 articles:
HTML format

Single Articles

    August 2021
  1. OIKONOMOU V, Break TJ, Gaffen SL, Moutsopoulos NM, et al
    Infections in the monogenic autoimmune syndrome APECED.
    Curr Opin Immunol. 2021;72:286-297.
    PubMed     Abstract available

    July 2021
  2. BIGLEY TM, Cooper MA
    Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation.
    Curr Opin Immunol. 2021;72:230-238.
    PubMed     Abstract available

    June 2021
  3. SHIH HP, Ding JY, Yeh CF, Chi CY, et al
    Anti-interferon-gamma autoantibody-associated immunodeficiency.
    Curr Opin Immunol. 2021;72:206-214.
    PubMed     Abstract available

    April 2021
  4. STREETER HB, Wraith DC
    Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases.
    Curr Opin Immunol. 2021;70:75-81.
    PubMed     Abstract available

    Autoimmunity, IgE and FcepsilonRI-bearing cells.
    Curr Opin Immunol. 2021;72:43-50.
    PubMed     Abstract available

    January 2021
  6. CROWTHER MD, Sewell AK
    The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease.
    Curr Opin Immunol. 2021;69:10-17.
    PubMed     Abstract available

    December 2020
  7. LA CAVA A
    Editorial overview: Research progress in autoimmunity: an overview and update.
    Curr Opin Immunol. 2020;67:iii-v.

    November 2020
  8. POSTAL M, Vivaldo JF, Fernandez-Ruiz R, Paredes JL, et al
    Type I interferon in the pathogenesis of systemic lupus erythematosus.
    Curr Opin Immunol. 2020;67:87-94.
    PubMed     Abstract available

  9. PLACE DE, Kanneganti TD
    The innate immune system and cell death in autoinflammatory and autoimmune disease.
    Curr Opin Immunol. 2020;67:95-105.
    PubMed     Abstract available

  10. MORONEY JB, Chupp DP, Xu Z, Zan H, et al
    Epigenetics of the antibody and autoantibody response.
    Curr Opin Immunol. 2020;67:75-86.
    PubMed     Abstract available

    October 2020
  11. PAWLAK M, Ho AW, Kuchroo VK
    Cytokines and transcription factors in the differentiation of CD4(+) T helper cell subsets and induction of tissue inflammation and autoimmunity.
    Curr Opin Immunol. 2020;67:57-67.
    PubMed     Abstract available

    September 2020
  12. LINCOLN MR, Axisa PP, Hafler DA
    Epigenetic fine-mapping: identification of causal mechanisms for autoimmunity.
    Curr Opin Immunol. 2020;67:50-56.
    PubMed     Abstract available

    August 2020
  13. MIKAMI N, Kawakami R, Sakaguchi S
    New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression.
    Curr Opin Immunol. 2020;67:36-41.
    PubMed     Abstract available

  14. GALGANI M, Bruzzaniti S, Matarese G
    Immunometabolism and autoimmunity.
    Curr Opin Immunol. 2020;67:10-17.
    PubMed     Abstract available

    June 2020
  15. GREBINOSKI S, Vignali DA
    Inhibitory receptor agonists: the future of autoimmune disease therapeutics?
    Curr Opin Immunol. 2020;67:1-9.
    PubMed     Abstract available

    May 2020
  16. SHIPMAN WD, Sandoval MJ, Veiga K, Donlin LT, et al
    Fibroblast subtypes in tissues affected by autoimmunity: with lessons from lymph node fibroblasts.
    Curr Opin Immunol. 2020;64:63-70.
    PubMed     Abstract available

    December 2019
  17. SANZ I, Lund F
    Complexity and heterogeneity - the defining features of autoimmune disease.
    Curr Opin Immunol. 2019;61:iii-vi.

    November 2019
  18. BARNAS JL, Looney RJ, Anolik JH
    B cell targeted therapies in autoimmune disease.
    Curr Opin Immunol. 2019;61:92-99.
    PubMed     Abstract available

    October 2019
  19. CHANG HD, Tokoyoda K, Hoyer B, Alexander T, et al
    Pathogenic memory plasma cells in autoimmunity.
    Curr Opin Immunol. 2019;61:86-91.

  20. SILVERMAN GJ, Azzouz DF, Alekseyenko AV
    Systemic Lupus Erythematosus and dysbiosis in the microbiome: cause or effect or both?
    Curr Opin Immunol. 2019;61:80-85.
    PubMed     Abstract available

    September 2019
  21. ELLEBRECHT CT, Lundgren DK, Payne AS
    On the mark: genetically engineered immunotherapies for autoimmunity.
    Curr Opin Immunol. 2019;61:69-73.
    PubMed     Abstract available

  22. SLIGHT-WEBB S, Bourn RL, Holers VM, James JA, et al
    Shared and unique immune alterations in pre-clinical autoimmunity.
    Curr Opin Immunol. 2019;61:60-68.
    PubMed     Abstract available

    Autoimmune complications of cancer immunotherapy.
    Curr Opin Immunol. 2019;61:54-59.
    PubMed     Abstract available

    August 2019
  24. STEINMAN L, Ho PP, Robinson WH, Utz PJ, et al
    Antigen-specific tolerance to self-antigens in protein replacement therapy, gene therapy and autoimmunity.
    Curr Opin Immunol. 2019;61:46-53.
    PubMed     Abstract available

  25. THI CUC B, Pohar J, Fillatreau S
    Understanding regulatory B cells in autoimmune diseases: the case of multiple sclerosis.
    Curr Opin Immunol. 2019;61:26-32.
    PubMed     Abstract available

  26. TENG X, Cornaby C, Li W, Morel L, et al
    Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.
    Curr Opin Immunol. 2019;61:10-16.
    PubMed     Abstract available

    July 2019
  27. SETH A, Craft J
    Spatial and functional heterogeneity of follicular helper T cells in autoimmunity.
    Curr Opin Immunol. 2019;61:1-9.
    PubMed     Abstract available

    March 2019
  28. FAHMY AM, Boulais J, Desjardins M, Matheoud D, et al
    Mitochondrial antigen presentation: a mechanism linking Parkinson's disease to autoimmunity.
    Curr Opin Immunol. 2019;58:31-37.
    PubMed     Abstract available

    February 2019
  29. CORSIERO E, Delvecchio FR, Bombardieri M, Pitzalis C, et al
    B cells in the formation of tertiary lymphoid organs in autoimmunity, transplantation and tumorigenesis.
    Curr Opin Immunol. 2019;57:46-52.
    PubMed     Abstract available

  30. DALMAS E
    Innate immune priming of insulin secretion.
    Curr Opin Immunol. 2019;56:44-49.
    PubMed     Abstract available

  31. COQUEL F, Neumayer C, Lin YL, Pasero P, et al
    SAMHD1 and the innate immune response to cytosolic DNA during DNA replication.
    Curr Opin Immunol. 2019;56:24-30.
    PubMed     Abstract available

    December 2018
    Editorial overview: Autoimmunity: A new frontier awaits.
    Curr Opin Immunol. 2018;55:iii-iv.

    November 2018
  33. RISTORI G, Faustman D, Matarese G, Romano S, et al
    Bridging the gap between vaccination with Bacille Calmette-Guerin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis.
    Curr Opin Immunol. 2018;55:89-96.
    PubMed     Abstract available

    October 2018
  34. HALE M, Rawlings DJ, Jackson SW
    The long and the short of it: insights into the cellular source of autoantibodies as revealed by B cell depletion therapy.
    Curr Opin Immunol. 2018;55:81-88.
    PubMed     Abstract available

  35. PHALKE S, Marrack P
    Age (autoimmunity) associated B cells (ABCs) and their relatives.
    Curr Opin Immunol. 2018;55:75-80.
    PubMed     Abstract available

    September 2018
  36. OUKKA M, Bettelli E
    Regulation of lymphocyte trafficking in central nervous system autoimmunity.
    Curr Opin Immunol. 2018;55:38-43.
    PubMed     Abstract available

  37. JONES BE, Maerz MD, Buckner JH
    IL-6: a cytokine at the crossroads of autoimmunity.
    Curr Opin Immunol. 2018;55:9-14.
    PubMed     Abstract available

  38. MEDINA CO, Nagy N, Bollyky PL
    Extracellular matrix and the maintenance and loss of peripheral immune tolerance in autoimmune insulitis.
    Curr Opin Immunol. 2018;55:22-30.
    PubMed     Abstract available

  39. VOGELZANG A, Guerrini MM, Minato N, Fagarasan S, et al
    Microbiota - an amplifier of autoimmunity.
    Curr Opin Immunol. 2018;55:15-21.
    PubMed     Abstract available

    February 2018
    Natural killer cell education in human health and disease.
    Curr Opin Immunol. 2018;50:102-111.
    PubMed     Abstract available

    December 2017
  41. LO B, Lenardo MJ
    Editorial overview: Autoimmunity: New genomics approaches are improving our understanding of autoimmunity.
    Curr Opin Immunol. 2017;49:iv-vi.

    November 2017
  42. KRETSCHMER S, Lee-Kirsch MA
    Type I interferon-mediated autoinflammation and autoimmunity.
    Curr Opin Immunol. 2017;49:96-102.
    PubMed     Abstract available

  43. ROSE NR
    Negative selection, epitope mimicry and autoimmunity.
    Curr Opin Immunol. 2017;49:51-55.
    PubMed     Abstract available

    October 2017
  44. IVISON S, des Rosiers C, Lesage S, Rioux JD, et al
    Biomarker-guided stratification of autoimmune patients for biologic therapy.
    Curr Opin Immunol. 2017;49:56-63.
    PubMed     Abstract available

    September 2017
  45. DENDROU CA, Fugger L
    Immunomodulation in multiple sclerosis: promises and pitfalls.
    Curr Opin Immunol. 2017;49:37-43.
    PubMed     Abstract available

    August 2017
  46. ROMI F, Hong Y, Gilhus NE
    Pathophysiology and immunological profile of myasthenia gravis and its subgroups.
    Curr Opin Immunol. 2017;49:9-13.
    PubMed     Abstract available

    July 2017
  47. LIANG Y, Sarkar MK, Tsoi LC, Gudjonsson JE, et al
    Psoriasis: a mixed autoimmune and autoinflammatory disease.
    Curr Opin Immunol. 2017;49:1-8.
    PubMed     Abstract available

    April 2017
  48. WAN X, Unanue ER
    Unique features in the presentation of insulin epitopes in autoimmune diabetes: an update.
    Curr Opin Immunol. 2017;46:30-37.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.